BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32420338)

  • 1. Machine Learning Supports Long Noncoding RNAs as Expression Markers for Endometrial Carcinoma.
    Mello AC; Freitas M; Coutinho L; Falcon T; Matte U
    Biomed Res Int; 2020; 2020():3968279. PubMed ID: 32420338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of lncRNAs associated with uterine corpus endometrial cancer prognosis based on the competing endogenous RNA network.
    Wang L; Su X; Wang L; Luo J; Xiong Z; Leung GHD; Zhou J; Yang G; Zhai L; Zhang X; Liu Q; Lu G; Wang Y
    Int J Med Sci; 2023; 20(12):1600-1615. PubMed ID: 37859697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.
    Shan L; Lu Y; Xiang CC; Zhu X; Zuo ED; Cheng X
    J Immunol Res; 2022; 2022():2547029. PubMed ID: 35571565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma.
    Xie BF; Xia Y; Lin DH; Lian B; Zhang ML; Liu L; Qin CR
    Comput Intell Neurosci; 2022; 2022():6530884. PubMed ID: 36199963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma.
    Ouyang D; Li R; Li Y; Zhu X
    J Cell Biochem; 2019 Oct; 120(10):18465-18477. PubMed ID: 31168849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
    Wang P; Zeng Z; Shen X; Tian X; Ye Q
    DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning combined with single-cell analysis reveals predictive capacity and immunotherapy response of T cell exhaustion-associated lncRNAs in uterine corpus endometrial carcinoma.
    Jiang F; Tao Z; Zhang Y; Xie X; Bao Y; Hu Y; Ding J; Wu C
    Cell Signal; 2024 May; 117():111077. PubMed ID: 38311301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database.
    Zhang Y; Jin T; Shen H; Yan J; Guan M; Jin X
    Med Sci Monit; 2019 Dec; 25():9752-9769. PubMed ID: 31856144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of genomic instability-derived long non-coding RNA signature of endometrial cancer.
    Huo XL; Wang SF; Yang Q; Yu XL; Gu T; Hua HX; Yang M; Bai LL; Zhang XL
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):96-101. PubMed ID: 35181055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker.
    Mo X; Wu Y; Chen L; Zhai M; Gao Z; Hu K; Guo J
    J Clin Lab Anal; 2019 Feb; 33(2):e22692. PubMed ID: 30320481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
    Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M
    DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of ESRRA in Endometrial Cancer.
    Wang S; Huo X
    Technol Cancer Res Treat; 2021; 20():1533033821992083. PubMed ID: 33525981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
    Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
    J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma.
    Zhang Q; Wang Y; Xue F
    Genet Res (Camb); 2022; 2022():3217248. PubMed ID: 36186000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An miRNA signature associated with tumor mutation burden in endometrial cancer.
    Zhou H; Chen L; Qin M; Lei Y; Li T; Li H; Cheng X
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33141168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCGA dataset‑based construction and integrated analysis of aberrantly expressed long non‑coding RNA mediated competing endogenous RNA network in gastric cancer.
    He W; Zhang D; Li X; Wu J; Yang X; Wang Q; Lu W; Jiang J; Wu C
    Oncol Rep; 2018 Dec; 40(6):3511-3522. PubMed ID: 30272352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.